Insider · CIK 0001276700

Karbe Frank

CIK 0001276700 Name as filed on the most recent filing

Filed as Karbe Frank (21)

28 transaction lines · from 21 filings · filed 2008-10-31 to 2024-12-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

28 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-12-13 P, Open-market purchase Phathom Pharmaceuticals, Inc.PHAT 99,084, acquired Open Form 4 filing 0000950170-24-136391
2023-07-27 P, Open-market purchase Better Therapeutics, Inc.BTTX 100,000, acquired Open Form 4 filing 0000950170-23-035680
2023-04-10 P, Open-market purchase Better Therapeutics, Inc.BTTX 200,000, acquired Open Form 4 filing 0000899243-23-011189
2022-09-15 P, Open-market purchase Better Therapeutics, Inc.BTTX 104,695, acquired Open Form 4 filing 0000899243-22-031206
2021-07-07 S, Open-market sale Myovant Sciences Ltd.MYOV 70,296, disposed Open Form 4 filing 0001209191-21-046171
2021-04-06 S, Open-market sale Myovant Sciences Ltd.MYOV 206,420, disposed Open Form 4 filing 0001209191-21-026084
2021-02-16 S, Open-market sale Myovant Sciences Ltd.MYOV 16,050, disposed Open Form 4 filing 0001209191-21-011894
2021-01-28 S, Open-market sale Myovant Sciences Ltd.MYOV 7,200, disposed Open Form 4 filing 0001209191-21-006444
2021-01-15 S, Open-market sale Myovant Sciences Ltd.MYOV 16,125, disposed Open Form 4 filing 0001209191-21-004328
2020-12-28 S, Open-market sale Myovant Sciences Ltd.MYOV 354,000, disposed Open Form 4 filing 0001209191-20-065511
2020-12-15 S, Open-market sale Myovant Sciences Ltd.MYOV 2 lines 25,363, disposed Open Form 4 filing 0001209191-20-064096
2020-11-30 S, Open-market sale Myovant Sciences Ltd.MYOV 36,000, disposed Open Form 4 filing 0001209191-20-061221
2020-11-17 S, Open-market sale Myovant Sciences Ltd.MYOV 15,000, disposed Open Form 4 filing 0001209191-20-059450
2020-11-13 S, Open-market sale Myovant Sciences Ltd.MYOV 15,000, disposed Open Form 4 filing 0001209191-20-058894
2020-09-15 S, Open-market sale Myovant Sciences Ltd.MYOV 16,298, disposed Open Form 4 filing 0001209191-20-050887
2020-08-31 S, Open-market sale Myovant Sciences Ltd.MYOV 423,275, disposed Open Form 4 filing 0001209191-20-048927
2020-08-28 S, Open-market sale Myovant Sciences Ltd.MYOV 73,146, disposed Open Form 4 filing 0001209191-20-048927
2020-08-19 S, Open-market sale Myovant Sciences Ltd.MYOV 14,000, disposed Open Form 4 filing 0001209191-20-047968
2019-12-30 S, Open-market sale Myovant Sciences Ltd.MYOV 306,351, disposed Open Form 4 filing 0001209191-19-062187
2019-06-11 P, Open-market purchase Myovant Sciences Ltd.MYOV 72,800, acquired Open Form 4 filing 0001209191-19-036115
2010-08-24 P, Open-market purchase Exelixis IncEXEL 3 lines 49,165, acquired Open Form 4 filing 0001140361-10-035051
2008-10-31 P, Open-market purchase Exelixis IncEXEL 2 lines 25,250, acquired Open Form 4 filing 0001140361-08-024157
2008-10-30 P, Open-market purchase Exelixis IncEXEL 2 lines 32,125, acquired Open Form 4 filing 0001140361-08-024157

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 12
  • Open-market sale 16
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. KARBE FRANK, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001276700

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.